160 related articles for article (PubMed ID: 22652554)
1. Effect of genetic polymorphism of ALOX15 on aspirin-exacerbated respiratory disease.
Song YS; Yang EM; Kim SH; Jin HJ; Park HS
Int Arch Allergy Immunol; 2012; 159(2):157-61. PubMed ID: 22652554
[TBL] [Abstract][Full Text] [Related]
2. Potential association of DCBLD2 polymorphisms with fall rates of FEV(1) by aspirin provocation in Korean asthmatics.
Park TJ; Kim JH; Park BL; Cheong HS; Bae JS; Pasaje CF; Park JS; Uh ST; Kim MK; Choi IS; Park CS; Shin HD
J Korean Med Sci; 2012 Apr; 27(4):343-9. PubMed ID: 22468095
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between CD58 genetic variations and aspirin-exacerbated respiratory disease in a Korean population.
Pasaje CF; Bae JS; Park BL; Cheong HS; Jang AS; Uh ST; Kim MK; Kim JH; Park TJ; Lee JS; Kim Y; Park CS; Shin HD
J Asthma; 2011 Aug; 48(6):539-45. PubMed ID: 21726122
[TBL] [Abstract][Full Text] [Related]
4. Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease.
Palikhe NS; Kim SH; Cho BY; Ye YM; Choi GS; Park HS
Allergy; 2010 Mar; 65(3):338-46. PubMed ID: 19796209
[TBL] [Abstract][Full Text] [Related]
5. Heat shock protein 70 gene polymorphisms in Japanese patients with aspirin-exacerbated respiratory disease.
Kikuchi K; Abe S; Kodaira K; Yukawa T; Hozawa S; Mochizuki H; Kurosawa M
J Investig Med; 2013 Apr; 61(4):708-14. PubMed ID: 23392055
[TBL] [Abstract][Full Text] [Related]
6. Genetic association analysis of TAP1 and TAP2 polymorphisms with aspirin exacerbated respiratory disease and its FEV1 decline.
Kim JH; Park BL; Pasaje CF; Bae JS; Park JS; Park SW; Uh ST; Kim MK; Choi IS; Cho SH; Choi BW; Park CS; Shin HD
J Hum Genet; 2011 Sep; 56(9):652-9. PubMed ID: 21796142
[TBL] [Abstract][Full Text] [Related]
7. Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease.
Stevens WW; Staudacher AG; Hulse KE; Carter RG; Winter DR; Abdala-Valencia H; Kato A; Suh L; Norton JE; Huang JH; Peters AT; Grammer LC; Price CPE; Conley DB; Shintani-Smith S; Tan BK; Welch KC; Kern RC; Schleimer RP
J Allergy Clin Immunol; 2021 Feb; 147(2):600-612. PubMed ID: 32371071
[TBL] [Abstract][Full Text] [Related]
8. Association of FANCC polymorphisms with FEV1 decline in aspirin exacerbated respiratory disease.
Kim JH; Park BL; Pasaje CF; Bae JS; Park JS; Park SW; Uh ST; Choi JS; Kim YH; Kim MK; Choi IS; Cho SH; Choi BW; Park CS; Shin HD
Mol Biol Rep; 2012 Mar; 39(3):2385-94. PubMed ID: 21670957
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the OBSCN nonsynonymous variants to aspirin exacerbated respiratory disease susceptibility in Korean population.
Kim JH; Park BL; Pasaje CF; Kim Y; Bae JS; Park JS; Uh ST; Kim YH; Kim MK; Choi IS; Cho SH; Choi BW; Koh I; Park CS; Shin HD
DNA Cell Biol; 2012 Jun; 31(6):1001-9. PubMed ID: 22251166
[TBL] [Abstract][Full Text] [Related]
10. Association analysis of ILVBL gene polymorphisms with aspirin-exacerbated respiratory disease in asthma.
Chang HS; Park JS; Lee HS; Lyu J; Son JH; Choi IS; Shin HD; Park CS
BMC Pulm Med; 2017 Dec; 17(1):210. PubMed ID: 29246216
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl-peptidase 10 as a genetic biomarker for the aspirin-exacerbated respiratory disease phenotype.
Kim SH; Choi H; Yoon MG; Ye YM; Park HS
Ann Allergy Asthma Immunol; 2015 Mar; 114(3):208-13. PubMed ID: 25592153
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population.
Park BL; Kim TH; Kim JH; Bae JS; Pasaje CF; Cheong HS; Kim LH; Park JS; Lee HS; Kim MS; Choi IS; Choi BW; Kim MK; Shin S; Shin HD; Park CS
Hum Genet; 2013 Mar; 132(3):313-21. PubMed ID: 23180272
[TBL] [Abstract][Full Text] [Related]
13. Lack of association of ALOX12 and ALOX15 polymorphisms with aspirin-exacerbated respiratory disease in Korean patients.
Lee HY; Kim SH; Ye YM; Choi GS; Park HS
Ann Allergy Asthma Immunol; 2009 Jul; 103(1):84-6. PubMed ID: 19663136
[No Abstract] [Full Text] [Related]
14. Arg16Gly β2-adrenergic receptor gene polymorphism in Japanese patients with aspirin-exacerbated respiratory disease.
Kohyama K; Abe S; Kodaira K; Yukawa T; Hozawa S; Morioka J; Inamura H; Ota M; Sagara H; Schwartz LB; Kurosawa M
Int Arch Allergy Immunol; 2011; 156(4):405-11. PubMed ID: 21829036
[TBL] [Abstract][Full Text] [Related]
15. Effect of diffuse panbronchiolitis critical region 1 polymorphisms on the risk of aspirin-exacerbated respiratory disease in Korean asthmatics.
Lee JS; Bae JS; Kim JH; Kim JY; Park TJ; Pasaje CF; Park BL; Cheong HS; Uh ST; Park JS; Park CS; Shin HD
Respir Care; 2012 May; 57(5):758-63. PubMed ID: 22152429
[TBL] [Abstract][Full Text] [Related]
16. Update on recent advances in the management of aspirin exacerbated respiratory disease.
Palikhe NS; Kim JH; Park HS
Yonsei Med J; 2009 Dec; 50(6):744-50. PubMed ID: 20046412
[TBL] [Abstract][Full Text] [Related]
17. A genetic effect of IL-5 receptor α polymorphism in patients with aspirin-exacerbated respiratory disease.
Losol P; Kim SH; Shin YS; Ye YM; Park HS
Exp Mol Med; 2013 Mar; 45(3):e14. PubMed ID: 23470716
[TBL] [Abstract][Full Text] [Related]
18. HLA-DRB and HLA-DQ genetic variability in patients with aspirin-exacerbated respiratory disease.
Esmaeilzadeh H; Nabavi M; Amirzargar AA; Aryan Z; Arshi S; Bemanian MH; Fallahpour M; Mortazavi N; Rezaei N
Am J Rhinol Allergy; 2015; 29(3):e63-9. PubMed ID: 25975240
[TBL] [Abstract][Full Text] [Related]
19. Association analysis of FABP1 gene polymorphisms with aspirin-exacerbated respiratory disease in asthma.
Chang HS; Park JS; Shin HR; Park BL; Shin HD; Park CS
Exp Lung Res; 2014 Dec; 40(10):485-94. PubMed ID: 25338211
[TBL] [Abstract][Full Text] [Related]
20. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
Steinke JW; Liu L; Huyett P; Negri J; Payne SC; Borish L
J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
